Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
4.600
+0.040 (0.88%)
At close: May 12, 2025

EGX:RMDA Revenue

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) had revenue of 451.63M EGP in the quarter ending March 31, 2025, a decrease of -1.01%. This brings the company's revenue in the last twelve months to 2.36B, down -1.35% year-over-year. In the year 2024, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) had annual revenue of 2.77B with 44.03% growth.

Revenue (ttm)
2.36B
Revenue Growth
-1.35%
P/S Ratio
2.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.77B846.34M44.03%
Dec 31, 20231.92B438.40M29.54%
Dec 31, 20221.48B237.52M19.06%
Dec 31, 20211.25B286.27M29.81%
Dec 31, 2020960.17M66.20M7.41%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition